Healthy volunteers help Fine-Tune experimental drug vonafexor
NCT ID NCT07251153
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing two forms of the experimental drug vonafexor (EYP651) in 40 healthy adults. The goal is to compare how the body processes the acid form versus the lysine salt form, and to check for interactions with other common medications. Results will guide future studies, but this trial does not test the drug's ability to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vonafexor (EYP651)
- What this could lead to
- If successful, this study could help determine the best form of vonafexor for future trials and how it interacts with other drugs.
- What could go wrong
- This is an early Phase 1 trial in healthy volunteers, not patients. Results may not predict effects in people with the target disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE AND FEMALE VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eurofins Optimed
RECRUITINGGières, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can 10-Minute exercise snacks replace the gym marathon?
- Can a common ADHD drug truly sharpen a healthy mind? a trial puts it to the test
- Breathe deep: new study reveals how slow breathing calms your Body's nerves
- New Gene-Targeting shot shows promise for cholesterol control
- New drug ORX489 put to the test in healthy adults
- Exercise before surgery: could ReHIIT boost recovery for bowel cancer patients?